Development Phase

What will Cures mean for biopharma R&D?

At almost 1,000 pages, the 21st Century Cures Act is quite literally a weighty piece of legislation that will have far-reaching consequences for pharma in 2017 and beyond.

Phil Taylor Dec 22, 2016 5:46am

Duke University in line for $19M to run neurological PhI trials

Jul 27, 2016 5:36am